CIPLA vs DRREDDY: Which Is Better on the Numbers?

Cipla Ltd (CIPLA) trades at ₹1397 on a P/E of 29.7, while Dr Reddys Laboratories Ltd (DRREDDY) trades at ₹1278 on a P/E of 25.4. On valuation, Dr Reddys Laboratories Ltd is cheaper on earnings (P/E 25.4 vs 29.7). This is a data comparison, not a recommendation.

Cipla Ltd

CIPLA
₹1,396.7

Dr Reddys Laboratories Ltd

DRREDDY
₹1,278.2

CIPLA vs DRREDDY — full comparison

MetricCIPLADRREDDY
Share price₹1,396.7₹1,278.2
P/E ratio (lower = cheaper)29.7025.40
ROE (higher = better)11.60%11.80%
ROCE (higher = better)15.50%13.60%
Dividend yield0.93%0.63%
Annualised return (history)-4.8%+2.3%
Volatility (lower = steadier)22%22%
1-year forecast (Monte Carlo median)₹1,291.7₹1,276.28
Cheapest MTF margin22% (Dhan)22% (Dhan)

How CIPLA and DRREDDY compare

Not investment advice. This page compares publicly available metrics and a statistical forecast for information only. The 1-year forecast is a Monte Carlo projection from historical volatility, not a prediction. Do your own research or consult a SEBI-registered adviser before investing.

More stock comparisons

Related tools